SI-BONE (SIBN) to Release Earnings on Monday

SI-BONE (NASDAQ:SIBN) is expected to be posting its quarterly earnings results after the market closes on Monday, February 24th. Analysts expect SI-BONE to post earnings of ($0.16) per share and revenue of $48.87 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

SI-BONE Price Performance

Shares of SIBN opened at $16.39 on Monday. SI-BONE has a fifty-two week low of $11.70 and a fifty-two week high of $21.19. The company has a 50 day moving average price of $15.26 and a 200-day moving average price of $14.55. The company has a debt-to-equity ratio of 0.22, a quick ratio of 7.22 and a current ratio of 8.25. The stock has a market capitalization of $687.40 million, a PE ratio of -17.82 and a beta of 1.17.

Wall Street Analysts Forecast Growth

SIBN has been the subject of a number of analyst reports. Needham & Company LLC reissued a “buy” rating and set a $19.00 target price on shares of SI-BONE in a research report on Monday, January 13th. Truist Financial increased their target price on shares of SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, SI-BONE presently has a consensus rating of “Buy” and an average target price of $23.00.

Insiders Place Their Bets

In other SI-BONE news, CFO Anshul Maheshwari sold 5,304 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $13.91, for a total value of $73,778.64. Following the completion of the transaction, the chief financial officer now owns 189,319 shares of the company’s stock, valued at approximately $2,633,427.29. This trade represents a 2.73 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Anthony J. Recupero sold 3,670 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $13.90, for a total transaction of $51,013.00. Following the completion of the sale, the insider now owns 222,814 shares in the company, valued at $3,097,114.60. The trade was a 1.62 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 9,311 shares of company stock valued at $130,356. Insiders own 3.90% of the company’s stock.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.